Menopause. Symptoms such as flushing, sleeplessness, headache, lack of concentration, associated with menopause
Conditions
Sponsors
Vice Chancellor for Research of Ahvaz Jundishapur University of Medical Science
Eligibility
Sex/Gender
Female
Age
47 Years to 62 Years
Inclusion criteria
Inclusion criteria: Eligible participants were naturally postmenopausal women aged 47–62 years, with 1 to 5 years since their last menstrual period. Additional inclusion criteria were: a score >11 on the FSDS-R questionnaire during pretest screening, being married, having no physical limitations for performing mindfulness exercises, and no prior participation in similar interventions within the previous six months.
Exclusion criteria
Exclusion criteria: Exclusion criteria included: presence of acute or chronic diseases or conditions affecting menopausal symptoms (e.g., thyroid disorders, cognitive impairment), recent adverse life events (within six months), use of hormone replacement therapy or topical estrogens (within six months), alcohol or drug abuse, antipsychotic medication use, and professional physical activity. Participants who missed more than two sessions, experienced a major stressor during the intervention, or expressed unwillingness to continue were withdrawn from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Health related quality of life. Timepoint: Before the intervention, Immediately after the intervention, Three months after the intervention completion. Method of measurement: Health related quality of life(SF36).;Female sexual distress. Timepoint: Before the intervention, Immediately after the intervention, Three months after the intervention completion. Method of measurement: Female sexual distress scale(FSDS). | — |
Secondary
| Measure | Time frame |
|---|---|
| Physical functioning(PF). Timepoint: Before the intervention, Immediately after the intervention, Three months after the intervention completion. Method of measurement: Questions 3 to 12 of SF36.;Role physical(RF). Timepoint: Before the intervention, Immediately after the intervention, Three months after the intervention completion. Method of measurement: Questions 13 to 16 of SF36.;Role emotional(RE). Timepoint: Before the intervention, Immediately after the intervention, Three months after the intervention completion. Method of measurement: Questions 17 to 19 of SF36.;Vitaity(VT). Timepoint: Before the intervention, Immediately after the intervention, Three months after the intervention completion. Method of measurement: questions 23, 27, 29 and 31 of SF36.;Mental health(MH). Timepoint: Before the intervention, Immediately after the intervention, Three months after the intervention completion. Method of measurement: questions 24, 25, 26, 28 and 30 of SF36.;Social functioning. Timepoint: Before the intervention, Immediately after the intervention, Three months after the intervention completion. Method of measurement: questions 20 and 32 of SF36.;Bodily pain(BP). Timepoint: Before the intervention, Immediately after the intervention, Three months after the intervention completion. Method of measurement: questions 21 and 22 of SF36.;General health(GH). Timepoint: Before the intervention, Immediately after the intervention, Three months after the intervention completion. Method of measurement: questions 1, 33 and 36 of SF36.;The Physical Component of Summary(PCS). Timepoint: Before the intervention, Immediately after the intervention, Three months after the intervention completion. Method of measurement: PF+RF+BP+GH dimensions of SF36 Questionnaire.;The Mental Component Summary(MCS). Timepoint: Before the intervention, Immediately after the intervention, Three months after the intervention completion. Method of measurement: SF+RE+MH+VT dimentions of SF36 Questionnaire | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMasoomeh Yazdani Aliabadi
Tarbiat Modares University
Outcome results
None listed